FIBROLOW LIDOSE

Antihyperlipidemic

Fenofibrate

Composition

Each capsule contains:
Fenofibrate 200 mg
Excipients q.s.

Presentations

30 lidose capsule pack

Indications

FIBROLOW Lidose is indicated as a complement to diet and non-pharmacological management (as exercise, weight reduction) in the next cases:

- Treatment of severe hypertriglyceridemia with or without low levels of HDL cholesterol.
- Mixed hyperlipidemia when statins are contraindicated or not tolerated by the patient.
- Mixed hyperlipidemia together with statin in patients with high cardiovascular risk, in whom triglycerides and HDL cholesterol have not been adequately controlled.